Delivery Order SPE2DR25D6029-SPE2DR26FXQ9D
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,546.80 on August 26, 2025, for the supply of Leucovorin Calcium 25 mg tablets (25-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 27, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This delivery order, awarded to AmerisourceBergen Drug Corp on December 17, 2025, provides Leucovorin Calcium 25 mg tablets in unit dose packaging of 20s to support federal medical supply requirements. The contract, valued at $1,157.22 with a firm fixed price structure, is funded by the Defense Logistics Agency and will be completed by December 18, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,934.70 to AmerisourceBergen Drug Corp for the supply of Leucovorin Calcium 500 mg vials. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of November 10, 2025, and represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order carries no set-aside designation and will be performed at...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $62,000 firm fixed price delivery order by the Defense Logistics Agency to provide 500mg/50ml vials of Leucovorin Calcium. The single day contract issued on June 28, 2023 has a period of performance through June 29, 2023. Under the delivery order, Amerisourcebergen will supply the pharmaceutical product to support the Defense Logistics Agency's medical supply chain activities operating out of...
- The Defense Logistics Agency awarded a $61,880 delivery order to Amerisourcebergen Drug Corporation for 4561691936 LEUCOVORIN CAL 500 MG/50 ML VL 50ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and calls for the delivery of this pharmaceutical product to a facility in Conshohocken, Pennsylvania. Performance will take place from August 3rd to August 4th, 2023, with the Defense Logistics Agency as the funding agency. No subcontractors or set...
- <p>Defense Logistics Agency awarded a firm fixed price delivery order for sixty-one dollars to Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, to supply LEUCOVORIN CAL 500 MG/50 ML VL 50ML. The delivery order has a potential value of sixty-one dollars and a completion date of October 19, 2023 under the base contract vehicle. No set-aside designation was applied to this award to supply the pharmaceutical product in support of DLA programs.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of L-methylfolate calcium 15 mg tablets (90-count bottles) valued at $1,325.90. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lazicluze 240 mg tablets (30-count units) with a ceiling value of $12,446.16. This firm fixed-price delivery order, with an ultimate completion date of July 9, 2025, represents a non-competitive set-aside transaction executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,270.19 firm fixed-price delivery order is for LEVORPHANOL TABS 2MG, with a period of performance through March 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- The Defense Logistics Agency awarded a delivery order valued at $3,319.13 to AmerisourceBergen Drug Corp for the supply of Levophed 4 mg/4 mL vials on December 15, 2025, with an ultimate completion date of December 16, 2025. This non-competed delivery order utilizes firm fixed pricing and is fulfilled from the place of performance located in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DR25D6029Indefinite Delivery Contract
- SPE2DR25D6029-SPE2DR26FXQ9DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,142.00 to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Leucovorin Calcium 5 mg tablets in quantities of 100 units. This is a firm fixed price delivery order with an ultimate completion date of December 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation, demonstrating AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a broad spectrum of medications and medical supplies to military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio encompasses specialty medications, vaccines, generic and brand-name drugs, and specialized medical supplies across multiple therapeutic domains, positioning it as a critical vendor for the Department of Defense's healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/18/25 |